Tuesday, September 27, 2022



Contact us 561.316.3330

Micron Biomedical Progresses with Clinical Evaluation of Its Technology for Measles-Rubella Vaccination

Under $6.745 Million Grant from the Bill & Melinda Gates Foundation

September 2, 2020

Micron Biomedical, Inc. recently received a second tranche of funding ($2.6M) to continue clinical development of its microneedle-based technology for measles and rubella vaccination from the Bill & Melinda Gates Foundation. This work leverages Micron’s technology, which has already been successfully evaluated in clinical studies including a Phase 1 trial of an FDA-approved seasonal influenza vaccine.

Micron Biomedical reports their applicator-free technology is well-suited for the administration of vaccines and, in particular, for measles-rubella vaccination in low- and middle-income countries as it is designed to offer the following benefits and advantages over-vaccination by standard hypodermic needle and syringe: strong immune response due to vaccine delivery to the skin, rich in immune system cells; administration by minimally-trained personnel; generation of sharps-free waste; small footprint; no need for reconstitution prior to use; and potential to reduce or eliminate the need for cold chain transportation and storage. “These benefits, along with the fact that the technology is painless, aim to increase recipients’ and vaccinators’ compliance and acceptability,” said Steven Damon, Micron’s CEO.

According to an April 7, 2020 Nature article, “Why measles deaths are surging — and coronavirus could make it worse,” there has been a 58% increase in measles cases and related deaths from 2016 to 2018, estimated to be 10 million worldwide with 140,000 deaths in 2018. Experts say the surge in measles cases and deaths worldwide is a result of multiple factors including the lack of access to vaccinations in poor countries, the refusal to vaccinate children in richer countries, and the suspension of measle vaccinations to focus on pandemics like COVID-19.

“We’re committed to utilizing our technology and experience towards the goal of achieving the elimination of measles and rubella, which can be devastating to children and families, especially in poorer countries. We are honored to be supported by the Gates Foundation as we continue our work together,” said Steven Damon.

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Our Sister Publication

Biotechnology News Magazine

By using this website you agree to accept Medical Device News Magazine Privacy Policy